Evidence map›Paper›PMID 37283579›Full record

ArticleFrontiers in cardiovascular medicine2023

A fully-automated low-cost cardiac monolayer optical mapping robot.

Peter Lee, Luqia Hou, Faisal J Alibhai, Rasha Al-Attar, Ana Simón-Chica, Andrés Redondo-Rodríguez, Yilin Nie, Maria Mirotsou, Michael A Laflamme, Gayathri Swaminath and 1 more

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Peter Lee *Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
Luqia Hou *Cardiometabolic Department, Merck & Co., Inc., South San Francisco, CA, United States.
Faisal J AlibhaiMcEwen Stem Cell Institute, University Health Network, Toronto, ON, Canada.
Rasha Al-AttarMcEwen Stem Cell Institute, University Health Network, Toronto, ON, Canada.
Ana Simón-ChicaNovel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
Andrés Redondo-RodríguezNovel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
Yilin NieCardiometabolic Department, Merck & Co., Inc., South San Francisco, CA, United States.
Maria MirotsouCardiometabolic Department, Merck & Co., Inc., South San Francisco, CA, United States.
Michael A LaflammeMcEwen Stem Cell Institute, University Health Network, Toronto, ON, Canada.
Gayathri SwaminathCardiometabolic Department, Merck & Co., Inc., South San Francisco, CA, United States.
David Filgueiras-RamaNovel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scalable and high-throughput electrophysiological measurement systems are necessary to accelerate the elucidation of cardiac diseases in drug development. Optical mapping is the primary method of simultaneously measuring several key electrophysiological parameters, such as action potentials, intracellular free calcium and conduction velocity, at high spatiotemporal resolution. This tool has been applied to isolated whole-hearts, whole-hearts in-vivo, tissue-slices and cardiac monolayers/tissue-constructs. Although optical mapping of all of these substrates have contributed to our understanding of ion-channels and fibrillation dynamics, cardiac monolayers/tissue-constructs are scalable macroscopic substrates that are particularly amenable to high-throughput interrogation. Here, we describe and validate a scalable and fully-automated monolayer optical mapping robot that requires no human intervention and with reasonable costs. As a proof-of-principle demonstration, we performed parallelized macroscopic optical mapping of calcium dynamics in the well-established neonatal-rat-ventricular-myocyte monolayer plated on standard 35 mm dishes. Given the advancements in regenerative and personalized medicine, we also performed parallelized macroscopic optical mapping of voltage dynamics in human pluripotent stem cell-derived cardiomyocyte monolayers using a genetically encoded voltage indictor and a commonly-used voltage sensitive dye to demonstrate the versatility of our system.

Indexed as

automationcalcium sensitive dyescardiac electrophysiologygenetically encoded voltage indicatorsoptical mappingroboticsvoltage sensitive dyes

Identifiers

PMID37283579
PMCPMC10240081

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.